Preparation method of methylprednisolone hemisuccinate impurity
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHONGQING HUABANGSHENGKAI PHARM
- Publication Date
- 2019-04-26
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of chemical synthesis, and specifically relates to a preparation method of 11β, 17α, 21-trihydroxy-6β-methylpregna-1,4-diene-3,20-diketone-21-succinate. Background technique
[0002] 11β, 17α, 21-trihydroxy-6β-methylpregna-1,4-diene-3,20-dione-21-succinate, is an impurity of methylprednisolone succinate, according to European Pharmacopoeia Record, the structural formula is as follows:
[0003]
[0004] Methylprednisolone succinate has the following structural formula:
[0005]
[0006] Methylprednisolone succinate is a synthetic glucocorticoid. Glucocorticoids diffuse through the cell membrane and bind to specific receptors in the cytoplasm. It has anti-inflammatory, immune and anti-allergic activities, used for symptomatic treatment of rheumatic diseases, collagen diseases, skin diseases, allergic symptoms, eye diseases, gastrointestinal diseases, respiratory diseases, edema, etc., as an immunosupp...